Literature DB >> 12354098

Mouse GSPT2, but not GSPT1, can substitute for yeast eRF3 in vivo.

Catherine Le Goff1, Olga Zemlyanko, Svetlana Moskalenko, Nadia Berkova, Sergei Inge-Vechtomov, Michel Philippe, Galina Zhouravleva.   

Abstract

BACKGROUND: The termination of protein synthesis in eukaryotes involves at least two polypeptide release factors (eRFs), eRF1 and eRF3. In mammals two genes encoding eRF3 structural homologues were identified and named GSPT1 and GSPT2.
RESULTS: In the present study, we demonstrate that mouse mGSPT2 but not mGSPT1 could functionally substitute the essential yeast gene SUP35. However, we show that the complementation property of mGSPT1 protein is modified when NH2-tagged by GST. Since mGSPT1 and mGSPT2 differ mainly in their N-terminal regions, we developed a series of N-terminal deleted constructs and tested them for complementation in yeast. We found that at least amino acids spanning 84-120 of mGSPT1 prevent the complementation of sup35 mutation. The fact that chimeras between mGSPT1, mGSPT2 and yeast Sup35 complement the disruption of the SUP35 gene indicates that the N-terminal region of mGSPT1 is not sufficient by itself to prevent complementation. Complementation of the mutant with a double disruption of SUP35 and SUP45 genes is obtained when mGSPT2 and human eRF1 are co-expressed but not by co-expression of mGSPT1 and human eRF1.
CONCLUSIONS: Our results strongly suggest that the two proteins (mGSPT1 and mGSPT2) are different. We hypothesize that the full length mGSPT1 does not have the properties expected for eRF3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354098     DOI: 10.1046/j.1365-2443.2002.00585.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  13 in total

Review 1.  Yeast prions assembly and propagation: contributions of the prion and non-prion moieties and the nature of assemblies.

Authors:  Mehdi Kabani; Ronald Melki
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

2.  Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.

Authors:  Céline Chauvin; Samia Salhi; Catherine Le Goff; Wildriss Viranaicken; Dialo Diop; Olivier Jean-Jean
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Functional role of Tia1/Pub1 and Sup35 prion domains: directing protein synthesis machinery to the tubulin cytoskeleton.

Authors:  Xiang Li; Joseph B Rayman; Eric R Kandel; Irina L Derkatch
Journal:  Mol Cell       Date:  2014-06-26       Impact factor: 17.970

4.  Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability.

Authors:  Annabel C Whibley; Vincent Plagnol; Patrick S Tarpey; Fatima Abidi; Tod Fullston; Maja K Choma; Catherine A Boucher; Lorraine Shepherd; Lionel Willatt; Georgina Parkin; Raffaella Smith; P Andrew Futreal; Marie Shaw; Jackie Boyle; Andrea Licata; Cindy Skinner; Roger E Stevenson; Gillian Turner; Michael Field; Anna Hackett; Charles E Schwartz; Jozef Gecz; Michael R Stratton; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2010-07-22       Impact factor: 11.025

5.  Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.

Authors:  Chelsea E Powell; Guangyan Du; Jianwei Che; Zhixiang He; Katherine A Donovan; Hong Yue; Eric S Wang; Radosław P Nowak; Tinghu Zhang; Eric S Fischer; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2020-09-28       Impact factor: 5.100

6.  The effect of eukaryotic release factor depletion on translation termination in human cell lines.

Authors:  Deanna M Janzen; Adam P Geballe
Journal:  Nucleic Acids Res       Date:  2004-08-23       Impact factor: 16.971

7.  Prion-dependent lethality of sup45 mutants in Saccharomyces cerevisiae.

Authors:  Denis Kiktev; Sergey Inge Vechtomov; Galina Zhouravleva
Journal:  Prion       Date:  2007-04-04       Impact factor: 3.931

8.  Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast.

Authors:  He Gong; Nina V Romanova; Kim D Allen; Pavithra Chandramowlishwaran; Kavita Gokhale; Gary P Newnam; Piotr Mieczkowski; Michael Y Sherman; Yury O Chernoff
Journal:  PLoS Genet       Date:  2012-04-19       Impact factor: 5.917

9.  On the Diversification of the Translation Apparatus across Eukaryotes.

Authors:  Greco Hernández; Christopher G Proud; Thomas Preiss; Armen Parsyan
Journal:  Comp Funct Genomics       Date:  2012-05-14

10.  Viable nonsense mutants for the essential gene SUP45 of Saccharomyces cerevisiae.

Authors:  Svetlana E Moskalenko; Svetlana V Chabelskaya; Sergei G Inge-Vechtomov; Michel Philippe; Galina A Zhouravleva
Journal:  BMC Mol Biol       Date:  2003-02-10       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.